ARCHIVES

ODAC’s Dilemma: Proposed Indication Created By Reliance On PSA Screening and Hormonal Treatment

This article is from The Cancer Letter archive.

Vol. 37 No. 35 | September 23, 2011

Download PDF Visit The Full Archive

Related Articles

Trapido To Lead NCI’s Epidemiology Program.

July 26, 2002

Cancer Planners Revise Some Project Areas, Drop Some, Add New Ones

February 8, 1974

Drug Approvals; Zykadia Granted Accelerated Approval For ALK+ NSCLC; ADXS-HPV Grated Orphan Drug Designation

May 9, 2014

Radiotherapy In Combination With Zometa Provide Pain Control For Advanced Myeloma

February 27, 2004

Cost of Care: Medicare Patients Charged More In Outpatient Care Settings

November 1, 2013

Construction, Pay Raise, Foundation Bills Clear Senate Committee

December 1, 1989